Firvanq(Vancomycin Hcl)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$510K
Medicare cost, 2024
$510K
Medicare cost, 2024
Medicare drug plans spent $510,110 on Firvanq (vancomycin hcl) in 2024, for 2,935 prescriptions and refills filled by 1,864 patients. Spending fell 57% from 2023 to 2024. California accounts for the most spending ($67,395, 13% of the total).
Medicare cost, 2024
$510K
-56.8% from 2023
Prescriptions
2,935
$173.80 per claim
Patients
1,864
1,754 prescribers
Total spending, 2024
$510K
$273.71 per patient
Questions and answers
How much does Medicare spend on Firvanq?
Medicare prescription drug plans paid $510K for Firvanq in 2024, for 2,935 prescriptions and refills to 1,864 patients (down 56.8% from 2023). The average cost per claim was $173.80.
Which state spends the most on Firvanq?
California had the highest Medicare cost for Firvanq in 2024: $67K for 334 claims, followed by Ohio ($53K).
Who prescribes Firvanq the most?
Steven J Nelson, family practice in Stockton, CA, had the highest Medicare cost for Firvanq in 2024: 26 claims costing $6,608.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Firvanq was $510K in 2024, after a high of $2.9M in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Firvanq, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Steven J Nelson Stockton, CA | Family Practice | 26 | Under 11 | $6,608 |
| Kamini Shah Baltimore, MD | Infectious Disease | 24 | Under 11 | $3,577 |
| Yue Yuan Indianapolis, IN | Internal Medicine | 17 | Under 11 | $3,076 |
| Nomy Thomas Jacob Baltimore, MD | Nurse Practitioner | 18 | Under 11 | $2,910 |
| Jeffrey R Cohen East Palestine, OH | Family Practice | 16 | Under 11 | $2,902 |
| Eugene Curley York, PA | Infectious Disease | 12 | Under 11 | $2,612 |
| Hsiu-Chuan Ho Cerritos, CA | Nurse Practitioner | 15 | Under 11 | $2,591 |
| Emad H Elbadawy Cleveland, OH | Internal Medicine | 15 | Under 11 | $2,440 |
| Summer R Afaneh Cleveland, OH | Nurse Practitioner | 15 | Under 11 | $2,396 |
| De Tan Sacramento, CA | Gastroenterology | 16 | Under 11 | $2,342 |
| Nicolas de la Pena Pittsburgh, PA | Infectious Disease | 21 | Under 11 | $2,291 |
| Andrew Lazris Columbia, MD | Internal Medicine | 16 | Under 11 | $2,251 |
| Anna Leszczynski Burlington, MA | Gastroenterology | 14 | Under 11 | $2,213 |
| Katherine T Brunner Boston, MA | Gastroenterology | 12 | Under 11 | $1,896 |
| Randy M Kreider Clarion, PA | Family Practice | 12 | Under 11 | $1,695 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 6,174 | 12,032 | 7,060 | $1.9M |
| 2023 | 3,954 | 7,228 | 4,341 | $1.2M |
| 2024 | 1,754 | 2,935 | 1,864 | $510K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Azurity Pharmac | 2,932 | $510K |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 4
- RxNorm concept IDs
- 2000127, 2000133, 2000134, 2000136
- Application numbers
- NDA208910
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through June 2026, 65,529 side-effect reports named vancomycin hydrochloride, the active ingredient of Firvanq (reports from 1999 on). 60,284 of them (92.0%) were serious, 12,915 named a death and 34,805 named a hospital stay. The reactions named most often were drug ineffective, acute kidney injury and off label use. 22,206 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
65,529
5,050 in 2025 (-3.1% from 2024)
Serious
92.0%
60,284 reports
Deaths named
12,915
19.7% of reports
Hospital stays
34,805
53.1% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
Since 2002. 2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Firvanq?
65,529 reports from 1999 through June 2026 named vancomycin hydrochloride, the active ingredient of Firvanq. 60,284 of them (92.0%) were serious, 12,915 named a death and 34,805 named a hospital stay.
What are the most reported side effects of Firvanq?
7,279 reports named drug ineffective, the reaction named most often, followed by acute kidney injury (4,892) and off label use (4,721). In the last 5 years the reaction named most often was drug ineffective (4,069 reports). A report can name several reactions.
How many side-effect reports named Firvanq in 2025?
5,050 reports were received in 2025 (-3.1% from 2024). 2026 so far: 2,096 reports through June 2026, and more keep arriving late.
Do side-effect reports prove that Firvanq caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Firvanq caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Drug approvals (1 approval on file for vancomycin hydrochloride) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (vancomycin hydrochloride) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.